Akari Therapeutics, Plc
AKTXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $15.84M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.22$29.32
- Volume (live)
- -
- Avg. volume (3M)
- 63.67K
Akari Therapeutics (AKTX) Stock Price & Financial Analysis
Akari Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $8.03 - $8.72 |
|---|---|
| 52-Week High | $29.32 |
| 52-Week Low | $0.22 |
| Open | $8.72 |
| Volume (last close) | 21.68K |
| Average Volume (3M) | 63.67K |
| 50-Day MA | $9.04 |
|---|---|
| 200-Day MA | $9.06 |
| 1-Year Change | +1005.14% |
| Market Cap | 15.84M |
|---|---|
| Shares Outstanding | 1.79M |
| Price to Book (P/B) | 0.85 |
| EV/EBITDA | -0.31 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Akari Therapeutics at a Glance
As of the Oct 16, 2026 close, Akari Therapeutics (AKTX) has a market capitalization of $15.84M.
As of its latest reported balance sheet, it holds $7.69M in cash and securities against $693.00K of debt, a net cash position of $7.00M.
Akari Therapeutics does not currently pay a dividend.
The share price is up 1005.1% over the past year. At $8.18 (the Oct 16, 2026 close) it sits within its 52-week range of $0.22 to $29.32, below its 200-day moving average of $9.06.
Frequently Asked Questions About Akari Therapeutics
What is the current stock price for AKTX?
As of the Oct 16, 2026 close, AKTX stock trades at $8.18. The 52-week range is $0.22–$29.32, with a day range of $8.03–$8.72.
What is the P/E ratio for AKTX?
The P/E ratio (Price-to-Earnings) for AKTX is shown in the Key Statistics section. This valuation metric helps compare Akari Therapeutics, Plc to industry peers.
Does AKTX pay dividends?
Akari Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for AKTX?
Analyst ratings and recommendations for AKTX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of AKTX?
As of the Oct 16, 2026 close, Akari Therapeutics's market capitalization is $14.7M, classifying it as a micro-cap company. Akari Therapeutics operates in the Healthcare sector within the Biotechnology industry.